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Contro versy has arisen concerning whether gender in-
fluences the prognosis after myocardial infarction. Al-
though some studies have shown there to be no difference
between the sexes, most have indicated a worse prognosis
for women, attributing this to differences in baseline
characteristics. It has been further suggested that black
women have a particularly poor prognosis after infarc-
tion. To determine the contribution of gender and race
to the course of infarction, 816 patients with confirmed
myocardial infarction who were enrolled in the Multi-
center Investigation of the Limitation of Infarct Size
(MILlS) were analyzed. Of those patients, 226 were
women and 590 were men, 142 were black and 674 were
white.
The cumulative mortality rate at 48 months was 36%
for women versus 21% for men (p < 0.001, mean follow-
up 32 months). The cumulative mortality rate by race
The effect of gender on the prognosis after myocardial in-
farction is unclear. Although several studies (1,2) have found
either no difference in postinfarction progno sis between the
sexes or a worse prognosis for men (3), most studies (4, 5)
have shown a higher mortal ity rate in women than in men.
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was 34% for blacks versus 24% for whites (p < 0.005).
Both women and blacks exhibited more baseline char-
acteristics predictive of mortality than did their male or
white counterparts. It was possible to account for the
greater mortality rate of blacks by identifiable baseline
variables; however, even after adjustment, the mortality
rate for womenremained significantly higher (p < 0.(02).
The poorer prognosis for women was influenced by a
particularly high mortality rate among black women
(48%); the mortality rate for white women was 32%,
for black men 23% and for white men 21%. The mor-
tality for black women wassignificantlygreater than that
of the other subgroups. Thus, findings in the MILlS
population indicate that the prognosis after myocardial
infarction is worse for women, particularly black women.
(J Am Coli Cardiol; 9:473-82)
In the Fram ingham Study (4), the 12 month mortality rate
after a recognized myocardial infarction was 34% for women
compared with 19% for men . It has been suggested (6) that
the worse prognosis observed in women is due to an in-
creased prevalence in women of baseline predictors of mor-
tality . Women with infarction are typically older and have
a greater prevalence of hyperten sion and diabetes mellitu s
than do men with infarction (7- 9).
Although no consistent gender differences in complica-
tions after infarction have been shown, individual studies
(10) have suggested that women have a higher frequenc y
of reinfarction , a selectively worse prognosis after inferior
infarction (6) and a greater prevalence of cardiac rupture
after infarction (11) . Racial differences in the expression of
coronary heart disease have also been described. Although
black women seem to have a higher prevalence of, and
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mortality rate from, coronary heart disease than do white
women, there appear to be no such differences between
black and white men (12).
The data base from the Multicenter Investigation of the
Limitation of Infarct Size (MIllS) provides a unique op-
portunity to investigate the influence of both gender and
race on the course of a large number of patients with acute
infarction. Although the primary purpose of the study was
to assess the efficacy of hyaluronidase and propranolol ther-
apy on acute myocardial infarction (13), extensive data,
including baseline tests of left ventricular function and long-
term mortality status, were collected on all patients.
The specific objectives of our study were to determine:
I) Whether gender or race influences survival after myo-
cardial infarction; and 2) whether any observed differences
in survival could be accounted for by differences in baseline
characteristics between the genders and races.
Methods
TheMILlSpatient population. The structure of MIllS
and a list of participating institutions are presented in the
Appendix. Patients were eligible for enrollment in MIllS
if they were <76 years old, had ~30 minutes of pain typical
of myocardial ischemia, had been evaluated < 18 hours after
the onset of chest pain and demonstrated electrocardio-
graphic changes suggestive of acute ischemia or evolving
infarction (new Q waves greater than 30 ms in width and
~0.2 mY in depth, or ST segment elevation or depression,
or both, of ~O.I mY in at least two related leads) or left
bundle branch block or idioventricular rhythm. Exclusion
criteria, methods of informed consent, guidelines for stand-
ard care and details of the administration of hyaluronidase
or propranolol have been reported previously (13-15).
From the9,450patientsscreened, 985 wererandomized.
The study population in this report comprised 816 patients
who were of the white or black race and in whom an acute
infarction was confirmed by the creatine kinase (CK) core
laboratory. Of these 816 patients, 226 were women and 590
were men, 142were black and 674 were white. When grouped
by race and gender, there were 63 black women, 79 black
men, 163 white women and 511 white men.
Data collection. After enrollment but before random-
ization, baseline measurements including a 12 lead electro-
cardiogram and a rest radionuclide ventriculogram were ob-
tained. The left ventricular ejection fraction was calculated
from the ventriculogram by a semiautomated count method
from the left anterior oblique view after background cor-
rection (16). Radionuclide ventriculography was repeated
on the 10th day. Serial blood sample collections for mea-
surement of CK and the MB CK isoenzyme were initiated
before randomization and were continued for the length of
the hospital stay, as previously reported. Throughout the
hospitalization, a MIllS data coordinator recorded details
ofthe patients' history and physical examination, a summary
of daily clinical events, vital signs and special procedures
and results of routine laboratory tests.
Follow-up examinations wereconducted 3 and 6 months
after randomization. The vital status of all patients was
ascertained at 6 month intervals by a questionnaire admin-
istered by telephone. Core laboratories unaware of treatment
assignment and mortality outcome analyzed total CK activ-
ity, MB CK activity, electrocardiographic localization of
infarction and radionuclide ventriculography.
Table 1. Preinfarction Characteristics of 816 Patients
Gender Race
Women Men Black White
(n = 226) (n = 590) (n = 142) (n = 674)
Age (yr) 60 * 56 56 57
Hypertension (%) 63 * 50 70 * 50
Diabetes mellitus (%) 28 * 15 27 * 17
Cigarette smoking (pack' years) 34 * 43 33 42
Cigarette smoking within 6 54 54 58 53
months of MI (%)
Family history of MI age 40 * 31 27 34
«60 yr) (%)
History of congestive heart 12 * 7 14 * 7
failure (%)
History of hyperlipidemia (%) 10 10 9 II
History of angina >3 weeks 36 36 38 36
before MI (%)
Previous MI (%) 19 25 25 23
Obesity (%)t 52 50 51 50
*p < 0.05. tAn "obesity index" was calculated as weight in kilograms divided by height squared in meters.
A cutoff of 26 kg/m? was taken as the upper 25th percentile for the population. MI = myocardial infarction.
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Table 2. Hospital Course in 816 Patients
Gender Race
Women Men Black White
(n = 226) (n = 590) (n = 142) (n = 674)
LVEF
Admission (%) 49 * 45 50 * 46
10 Day (%) 51 * 47 50 48
Q wave MI (%) 54 65 53 64
Anterior MI (%) 58 56 59 57
Infarct size index 16 17 19 17
(MB CK gfiq/rrr')
Atrioventricular block (%) 28 * 19 19 22
Intraventricular 21 20 20 20
conduction delay (%)
Infarct extension (%) II 9 12 9
In-hospital death (%) 13 * 7 10 9
*p < 0.05. LVEF = left ventricular ejection fraction; MI = myocardial infarction.
Statistical methods. Within the gender and race groups,
chi-square and t tests were used to determine the significance
of the differences between proportions and means, respec-
tively. When multiple comparisons were made among the
four gender-race groups for a particular response, simul-
taneous inference methods were used to control the type I
error rate. Duncan's test (17) was applied when the response
was of a continuous nature and a technique developed by
Goodman (18) was used for categorical responses.
The Cox proportional hazards regression model (19) was
used to assess the differences in mortality to 48 months for
both gender and race while adjusting for the effects of a
"risk score" composed of baseline variables that showed
imbalances for sex or race or were found from the MILlS
population to predict mortality. The variables included in
the risk score were age, history of hypertension, diabetes,
smoking, history of congestive heart failure, family history
of myocardial infarction before age 60 years, level of ed-
ucation, Karnofsky score, history of cardiac arrhythmias,
use of diuretics in the 3 weeks before admission, transmural
Table 3. Follow-up
ischemia/infarction, the presence of ST elevation at ran-
domization, hypotension on admission and left ventricular
ejection fraction on admission. Unadjusted plots of the es-
timated cumulative mortality were produced by the Kaplan-
Meier method (20). Adjusted mortality curves were based
on the Kalbfleisch and Prentice discrete hazard model (21).
All probability (p) values were two-tailed and a p value of
<0.05 was considered significant.
Results
Influence of Gender on MyocardiaL Infarction
Preinfarction characteristics (Table 1). The mean age
of the women was greater than that of the men and the
women had a greater prevalence of hypertension, diabetes
mellitus, family history of infarction at less than 60 years
of age, and history of congestive heart failure before the
index infarction. Men had a more extensive history of cig-
arette smoking than did women; however, there was no
Women
(n = 183)
Gender
Men
(n = 531)
Black
(n = 122)
Race
White
(n = 592)
At 6 months'[
Angina pectoris (%) 58 * 44 49
Congestive heart failure (%) 32 18 33
Recurrent MI (%) 19 * 12 15
At end of follow-upj
Mortality rate for hospital 27 * 15 27
survivors (%)
Total cumulative mortality (%) 36 * 21 34
48
* 19
14
17
* 24
*p < 0.05; tsignificance of differences between proportions determined by chi-square test; tsignificance
of differences for 48 month mortality based on life table analysis; mean duration of follow up 32 months.
MI = myocardial infarction.
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Figure I. Mortality curves for women and men after myocardial
infarction, unadjusted (A) and adjusted (B) by the risk score.
significantly higher cumulative mortality rate than did whites
(34 versus 24%, p < 0.005) (Fig. 2A). However, when
adjusted for baseline risk variables, the difference in mor-
tality probability between blacks and whites was no longer
significant (Fig. 2B). Blacks had a higher cardiac mortality
rate than did whites (27 versus 21%, P < 0.04).
Combined Influence of Gender and Race on
Myocardial Infarction
The ratio of women to men in this study was markedly
higher for blacks than for whites (0.8: I versus 0.3 : I, P <
0.001); that is, 44% of the black patients and 24% of the
white patients were women.
Preinfarction characteristics (Table 4). Differences
between men and women similar to those observed in the
total population were present for both the black and white
races (Table 1). Statistical significance, however, was not
always reached because of both the smaller numbers in each
subgroup and the use of more stringent criteria for signifi-
cance (Duncan's test and Goodman's technique to control
against a type I error). Both black men and black women
had a significantly greater prevalence of hypertension before
infarction than did their white counterparts. A similar though
not significant trend was present for diabetes mellitus.
B
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Influence of Race on Myocardial Infarction
Preinfarction characteristics (Table 1). Before infarc-
tion, blacks had a greater prevalence of hypertension, di-
abetes mellitus and congestive heart failure than did whites.
Whites had a more extensive history of cigarette smoking.
Hospital course (Table 2). Blacks had a lower incidence
of Q wave infarction and a higher left ventricular ejection
fraction on admission than did whites. In-hospital mortality
was not significantly different between blacks and whites.
Follow-up (Tahle 3). Among hospital survivors of in-
farction, the mortality rate was greater for blacks than for
whites (27 versus 17%, p < 0.002). Blacks exhibited a
difference in the percent of men and women smoking within
the 6 months before infarction. The incidence of a prior
infarction, of angina more than 3 weeks before infarction
or of obesity was not significantly different between men
and women.
Hospital course (Table 2). The left ventricular ejection
fraction on admission was greater for women than for men
and remained greater for women at 10days. Although there
was no difference in infarct size index between men and
women, the infarct was more frequently associated with the
development of Q waves among men than among women.
There was no significant difference in location of infarction,
prevalence of intraventricular conduction delay or infarct
extension, although women had a greater prevalence of
atrioventricular conduction disturbance. There was no gen-
der difference in heart rate or blood pressure on admission.
The mortality rate during hospitalization was significantly
greater for women than for men.
Follow-up (Table 3). At the 6 month follow-up visit,
women had a higher incidence of angina pectoris, congestive
heart failure and reinfarction than did men. The frequency
of cardiac rupture (including ventricular septal defect) was
not significantly different between women (2.2%) and men
(1.7%), but the total number of cardiac ruptures was too
small to exclude a difference. There were no significant
differences in sex ratio for mortality between patients with
an anterior or an inferior infarction. The total mortality rate
after anterior infarction was 42% for women and 28% for
men (p = 0.003) and after inferior infarction it was 31%
for women and 16% for men (p = 0.001). The mortality
rate among hospital survivors was higher for women than
for men during follow-up (27 versus 15%, p < 0.001). The
48 month cumulative mortality rate was 36% for women
and 21% for men (p < 0.001) (Fig. IA). After adjustment
for the risk score, the mortality probability remained sig-
nificantly higher for women (p < 0.002) (Fig. IB). When
the data were analyzed specifically for death because of
cardiac causes, the mortality rate among women remained
significantly higher than that for men (31 versus 18%, P <
0.001).
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this difference was statistically significant only in black
patients. Black women had a significantly greater infarct
size index than did white women, Hospital course was not
different for black and white men except that white men
had more Q wave infarcts than did black men. The in-
hospital mortality rate was markedly higher for black women
than for black men.
Follow-up (Table 6). After infarction, both black and
white women had a greater incidence of angina and heart
failure than did their male counterparts, although these dif-
ferences were statistically significant only in black women,
The overall mortality, as well as the mortality among hos-
pital survivors, was significantly greater for black and white
women than for black and white men, respectively, Al-
though black and white men had a similar follow-up course,
black women had a greater mortality than did white women.
The mortality curves by gender and race are displayed as
both unadjusted (Fig, 3A) and adjusted by risk score (Fig.
3B); by both methods, the mortality of black women by life
table analysis was significantly greater than that of the other
subgroups. The significantly greater mortality among black
women persisted when only death from cardiac causes was
considered.
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Figure 2. Mortality curves by race after myocardial infarction,
unadjusted (A) and adjusted (B) by the risk score.
Hospital course (Table 5). White women had a lower
incidence of Q wave infarction than did white men. The
left ventricular ejection fraction was greater in both white
and black women than in their male counterparts, although
Causes of Death (Table 7)
There were no significant differences in the mortality
profiles of the various subgroups, Compared with whites,
blacks showed a trend toward a greater incidence of death
from a cardiovascular but noncoronary cause, which in-
cludes cerebrovascular-related death, and from noncardio-
vascular causes.
Table 4. Preinfarction Characteristics of 816 Patients by Gender and Race
Gender Within Race Race Within Gender
BW vs. BM WW vs. WM BW vs. WW BM vs. WM
(n = 63) (n = 79) (n = 163) (n = 511) (n = 63) (n = 163) (n = 79) (n = 511)
Age (yr) 58 * 55 61 * 56 58 * 61 55 56
Hypertension (%) 78 65 57 48 78 57 65 48
Diabetes mellitus (%) 37 19 25 * 14 37 25 19 14
Cigarette smoking 27 37 36 * 44 27 * 36 37 44
(pack' years)
Cigarette smoking within 54 61 53 53 54 53 61 53
6 months of MI (%)
Family history of MI 32 23 43 32 32 43 23 32
age <60 yr (%)
History of congestive 18 II 10 6 18 10 11 6
heart failure (%)
History of II 8 10 II II 10 8 II
hyperlipidemia (%)
History of angina>3 41 35 34 36 41 34 35 36
weeks before MI (%)
Previous MI (%) 24 27 18 25 24 18 27 25
Obesity (%) 62 42 49 51 62 49 42 51
*p < 0.05. BM = black men; BW = black women; MI = myocardial infarction; WM = white men; WW = white women.
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Table 5. Hospital Course in 816 Patients by Gender and Race
Gender Within Race Race WithinGender
BW vs. BM WW vs. WM BW vs. WW BM vs. WM
(n = 63) (n = 79) (n = 163) (n = 511) (n = 63) (n = 163) (n = 79) (n = 511 )
LVEF
Admission (%) 53 * 47 48 45 53 * 48 47 45
10Day (%) 52 * 48 51 47 52 51 48 47
Q wave MI (%) 56 50 53 * 67 56 53 50 * 67
Anterior MI (%) 62 56 57 57 62 57 56 57
Infarct size index 21 18 15 17 21 15 18 17
(MBCK gEq/m2)
Atrioventricular 21 18 30 * 20 21 30 18 20
block (%)
Intraventricular 18 22 22 20 18 22 22 20
conduction delay
(%)
Infarct extension (%) 18 8 9 9 18 9 8 9
In-hospital death (%) 18 * 4 II 8 18 II 4 8
*p < 0.05. Abbreviations as inTables I, 2 and 4.
Discussion
Although coronary heart disease is the most common
cause of death in women, its greater prevalence in men has
tended to lead to an underestimate of the extent of the
problem in women.
Influence of gender on prognosis. In the MILlS Study,
women had a worse prognosis after myocardial infarction
than did men. This difference was significant for both the
hospital and follow-up periods. As has been reported in
other studies (2,6,8), the women were older and had a
greater prevalence of hypertension, diabetes mellitus and
history of congestive heart failure before infarction. How-
ever, adjusting for these and other gender differences and
baseline predictors of mortality failed to explain the differ-
ence in prognosis. This may be due to a number of reasons.
Table 6. Follow-up in 714 Patients
Gender Within Race
First, there may be a differential effect of a particular risk
factor on women. For example, when associated with coro-
nary heart disease, diabetes mellitus has been shown to
convey a poorer prognosis for women than for men (22,23).
Second, there may be other known factors predictive of
mortality that differ between the sexes and that were not
evaluated in the Cox regression model. Third, there may be
unidentified gender-related differences in the response to
myocardial ischemia and infarction.
Gender difference in left ventricular ejection fraction.
Despite having a worse prognosis, women had a higher left
ventricularejection fractionthan did men, both on admission
and at 10days after infarction, A gender difference in ejec-
tion fraction is not present in normal individuals at rest (24).
However, in one angiographic study (25) of subjects with
chest pain but normal coronary arteries, the women had a
Race Within Gender
BW vs.
(n = 48)
BM WW vs.
(n = 74) (n = 135)
WM BW vs.
(n = 457) (n = 48)
WW BM vs.
(n = 135) (n = 74)
WM
(n = 457)
At 6 monthst
Angina pectoris (%) 69 36 55 46 69 55 36 46
Congestive heart 48 * 22 26 17 48 * 26 22 17
failure (%)
Recurrent MI (%) 22 II 18 12 22 18 II 12
At end of tollow-upt
Mortality for hospital 37 * 20 23 * 14 37 23 20 14
survivors (%)
Total cumulative 48 * 23 32 * 21 48 * 32 23 21
mortal ity (%)
*p < 0.05; tsignificance ofdifference between proportions determinedbychi-square testwith Goodman'scorrection formultiple tests; tsignificance
ofdifferences in 48 month mortality rate based on life table analysis; mean duration offollow up 32 months. Abbreviations as inTable 5.
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higher left ventricular ejection fraction than did the men.
Women in that study also had a higher heart rate than did
men, suggesting that the women exhibited a hyperdynamic
state causing both tachycardia and vigorous systolic func-
tion. However, in our study there was no gender difference
in heart rate at presentation. A study (26) of patients
undergoing coronary artery bypass grafting reported that
women have a higher preoperative left ventricular ejection
fraction than do men, although this may be due to the less
extensive coronary artery disease and a lesser degree of
previous infarction in the women undergoing surgery. Hakki
and Iskandrian (27) did not find a difference in ejection
fraction between men and women with a comparable extent
of coronary artery disease. Although left ventricular systolic
function may have been better in women than in men, the
left ventricular diastolic function in women may have been
more impaired. Heart failure due to diastolic stiffness in the
presence of preserved systolic function has been well de-
scribed in association with hypertension (28,29) and may
also be of significance in diabetes mellitus (30). Women
with infarction had a greater prevalence of both hypertension
and diabetes mellitus than did men. A greater degree of
diastolic dysfunction in women, if present, may contribute
Figure 3. Mortality curves by gender and race after myocardial
infarction. A, Unadjusted by the risk score. When considered
separately as pairs within gender and race, the mortality curves
were significantly different for black women andblack men (p <
0.00 1); white women and white men (p < 0.004); and black
women and white women (p < 0.02). B, After adjustment by the
risk score. When considered separately as pairs within gender and
race, the mortality curves were signifi cantly different for black
women and black men (p < 0.00 1); and black women and white
women (p < 0.01).
to the higher mortality rate observed among women despite
preserved systolic function.
Women had a higher incidence of initial non-Q wave
infarction in our study, as has been reported in other studies
(31,32). This finding would contribute to a better preserved
left ventricular ejection fraction among women. In addition,
it may explain in part the prevalence of reinfarction among
women within the first 6 months of follow-up. Marmor et
al. (10) reported that early recurrent infarction correlated
significantly with female sex in addition to non-Q wave
infarction. Cardiac rupture has also been proposed to occur
more commonly in women ( I I) . Although this complication
Table 7. Causes of Death in 122 Patients*
Gender Race Gender and Race
Women Men Black White BW WW BM WM
(n = 83) (n = 139) (n = 50) (n = 172) (n = 30) (n '" 53) (n = 20) (n = 119)
Arrhythmia (% ) 17 23 16 22 17 17 15 24
Coronary heart disease other 64 59 54 63 60 65 45 61
than primary arrhythmia
(%)
Cardiovascular other than 7 6 14 5 10 6 20 4
coronary heart disease (%)
Noncardiovascular (%) 7 6 10 5 10 6 10 5
Unknown (%) 5 6 6 5 3 6 10 6
*Refers to the profile of cause ofdeath within each group. There were no significant differences (p < 0 .05 by chi-square test) detected within the
groups. Abbreviations as in Table 5.
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did not occur more frequently in women in our study, there
were too few cases of cardiac rupture to clarify this point.
It has been suggested (6,33) that women with inferior in-
farction have an excess mortality over men, (that is, above
that seen with anterior infarction), owing to a greater prev-
alence of right coronary artery dominance. In our study,
women with inferior infarction did not have such an excess
mortality. The cause of death was not significantly different
between women and men. It has been found (26) that women
have a higher complication rate after coronary artery bypass
surgery, due in part to the smaller size of their coronary
arteries. The numbers were too small in our study to ade-
quately address this question.
Influence of race on prognosis. Although coronary heart
disease is the leading cause of death among blacks, there
is a lack of accurate information concerning its epidemiol-
ogy in the United States black population (12). We found
that blacks had a worse prognosis than did whites after
infarction. However, blacks also had a greater prevalence
of prior infarction, hypertension, diabetes mellitus and
congestive heart failure than did whites. In contrast to our
findings with respect to gender, when mortality rate was
adjusted for baseline differences, there was no significant
difference between the races. Analysis of the cause of death
by race showed interesting trends, although the numbers
were too small to achieve significance. Blacks showed a
trend toward a greater proportion of deaths due to both
noncoronary cardiovascular disease, such as cerebrovas-
cular disease, and noncardiovascular-related cause. Al-
though the former trend may reflect the greater prevalence
of hypertension and diabetes seen in blacks, both trends
may be a manifestation of a more generalized increased
mortality among blacks that is not confined to cardiovascular
disease (34). The ratio of the number of women to men in
the study was significantly higher among blacks. This phe-
nomenon, which has been noted previously (35,36), has not
been adequately explained but may reflect selection bias
resulting from factors such as delay among black men in
seeking medical attention. The concept that factors other
than left ventricular systolic function are responsible for
subsequent mortality is underscored by the observation that
black women had the lowest survival rate of the four groups
despite having the highest ejection fraction. Although blacks
had a worse prognosis overall than did whites, black men
showed no difference in prognosis from white men. This
supports the hypothesis that the higher mortality rate in
blacks after infarction may not be due to intrinsic racial
differences (37).
Clinical implications. Women, particularly black women,
have a significantly worse prognosis after myocardial in-
farction than do men. There is a need for further investi-
gation into the possible mechanisms for the gender and race
differences described. In addition, physicians must be con-
scious of the need for close attention to risk factor modi-
fication and clinical management of women, particularly
black women, with coronary artery disease.
We are indebted to Kathleen Carney for assistance in the preparation of
this manuscript.
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Barnes Hospital, Washington University School of Medicine,
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Rosanne Wettach, RN, MNP, Research Nurse Coordinator; Ava
Ysaguire, Susan Payne and Linda Wilson, Data Coordinators.
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Mary McHugh, RN, Research Nurse Coordinators; Harry
Garabedian, Data Coordinator.
Medical Center Hospital of Vermont, University of Vermont
College of Medicine, Burlington, VT. Daniel S. Raabe, Jr., MD,
Principal Investigator; Walter Gundel, MD; Marian Dornell, RN,
Maureen Hawley, RN, Patricia Beecher, RN, Kathleen Cornell,
RN, and Karen Helminger, RN, Research Nurse Coordinators;
Raina Maynard, Data Coordinator.
Harvard Medical School/Brigham and Women's Hospital,
Boston, MA. Eugene Braunwald, MD, Principal Investigator;Peter
H. Stone, MD, Joseph S. Alpert, MD and Robert Rude, MD,
Clinical Unit Directors; Nancy E. Taplin, RN, Kathryn Shea, RN,
Debbie Shiner, RN, Research Nurse Coordinators.
Parkland Memorial Hospital, University of Texas Health
Science Center at Dallas, TX. James T. Willerson, MD, Principal
Investigator; Robert E. Rude, MD, Clinical Unit Director; Charles
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